Docusate Sodium
- Product NDC
- 0121-0935
- 11-digit product format
- 001210935
- Labeler code
- 0121
- Product ID
- 0121-0935_5cfc4685-c885-4303-a988-5009cbd8e57b
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Docusate Sodium
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- PAI Holdings, LLC dba PAI Pharma
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2021-08-16
- Substance
- DOCUSATE SODIUM
- Active strength
- 50 mg/5mL
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 0121-0935 | 0121-0935-16 | D | Discontinued by firm | 2026-10-16 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 0121-0935 | 0121-0935-16 | D | Discontinued by firm | excluded / ndc_excluded.zip | d630ba8d3edf… | 732f749b63fb… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Docusate Sodium
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DOCUSATE SODIUM | 50 mg/5mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| F05Q2T2JA0 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1245686 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | Available on FDA.report |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0121-0935-05 | Docusate Sodium | 5 mL in 1 CUP, UNIT-DOSE | LIQUID | 5 | 9 | |
| 0121-0935-16 | Docusate Sodium | 473 mL in 1 BOTTLE | LIQUID | 473 | 9 | |
| 0121-0935-40 | Docusate Sodium | 10 in 1 TRAY | LIQUID | 10 | 9 | |
| 0121-0935-40 | Docusate Sodium | 4 in 1 CASE | LIQUID | 4 | 9 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0121-0935-05 | ML - Milliliter | 0121-0935 | bd4be1fb-4d63-4e7c-8bfa-2e34cd4de1c5 | 1 | 2021-10-08 |
| 0121-0935-16 | ML - Milliliter | 0121-0935 | 3bdd2684-e7df-4efc-abb2-b74bbcf7d516 | 1 | 2021-10-08 |
| 0121-0935-40 | ML - Milliliter | 0121-0935 | 3327600b-3340-46f6-b2a4-f6be1a4545bb | 1 | 2021-10-08 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Stool Softener | DOCUSATE SODIUM | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | f4671579-aed0-4f93-ab83-248e0d72b5b0 | 2026-08-10 | Warnings | M007 |
| Docusate Sodium Liquid | DOCUSATE SODIUM.50MG/5ML | Aldama Pharmaceuticals, Inc | 492b6d37-47cf-3a28-e063-6294a90a2a18 | 2026-08-10 | Warnings | M007 |
| Epsom Salt | MAGNESIUM SULFATE | Safeway Inc | 0b757160-f9eb-4413-9b43-97544c49c72f | 2026-08-10 | Warnings, Adverse reactions | M007 |
| Bisacodyl Laxative | BISACODYL | InvaDerm Corporation | 58ba9a9f-98d8-c380-e063-6294a90a774c | 2026-08-10 | Warnings | M007 |
| Sennosides | SENNOSIDES | Cardinal Health 107, LLC | 4a9e1cbe-ffe4-462f-a86d-078a357dcf49 | 2026-08-07 | Warnings | M007 |
| Senna S | DOCUSATE SODIUM, SENNOSIDES | Shield Pharmaceuticals Corp | 0be906d8-3db5-4218-bbdf-f1d126007990 | 2026-08-07 | Warnings | M007 |
| MiraFAST KIDS soft chews | MAGNESIUM HYDROXIDE | Bayer HealthCare LLC. | 58636827-239d-cc63-e063-6294a90a6180 | 2026-08-06 | Warnings | M007 |
| Stool Softener Extra Strength | DOCUSATE SODIUM | P & L Development, LLC | 4e97dd60-96e3-4b51-b614-c62480af1919 | 2026-08-06 | Warnings | M007 |
| Stool Softener Laxative | DOCUSATE SODIUM | P & L Development, LLC | 098d2377-0019-45fe-b995-700b1b1241c4 | 2026-08-05 | Warnings | M007 |
| Docusate Sodium softgels 50mg (Dye Free) | DOCUSATE SODIUM | CVS Pharmacy | 273ea95f-3c9c-98e8-e063-6294a90a2135 | 2026-08-05 | Warnings | M007 |
| Mineral Oil | MINERAL OIL | Old East Main Co. | 4bae831d-caba-40c9-bdb5-2611eac35dd5 | 2026-08-05 | Warnings, Adverse reactions | M007 |
| Metamucil Therapy for regularity | PSYLLIUM HUSK | Atlantic Biologicals Corp. | 57b112ea-f6b1-baa6-e063-6394a90a3b29 | 2026-08-05 | Warnings | M007 |
| WinCo Pure 5lb | PURE 5LB EPSOM SALT | WinCo Foods, LLC | 58529382-a192-cda2-e063-6394a90adb69 | 2026-08-05 | Warnings | M007 |
| Stool Softener Laxative | DOCUSATE SODIUM | P & L Development, LLC | cbb0edf4-1fa7-42f5-a6f7-027e3961b50a | 2026-08-05 | Warnings | M007 |
| Sennosides | SENNOSIDES | LEADER/ Cardinal Health 110, Inc. | e3c7ece8-82f3-cd0c-e053-2995a90ad800 | 2026-08-04 | Warnings | M007 |
| CVS Glycerin | GLYCERIN SUPPOISITORY | CVS Pharmacy, Inc | ca6d13db-60e8-4fcc-b7b3-3eb280b8c435 | 2026-08-04 | Warnings | M007 |
| Colace | DOCUSATE SODIUM | Atlantis Consumer Healthcare, Inc. | 7793fced-e8ee-44e2-b212-dd2a59a5f462 | 2026-08-04 | Warnings | M007 |
| Dual Action Senna Stool Softener | DOCUSATE SODIUM 50 MG, SENNOSIDES 8.6 MG | Shield Pharmaceuticals Corp | a04435df-aace-497f-a3a8-d8e8489db661 | 2026-08-03 | Warnings | M007 |
| Docusate Sodium - Stool Softener Laxative | DOCUSATE SODIUM | Cardinal Health 107, LLC | b5e4b14d-bf11-4309-bf6d-65ee9d877a24 | 2026-07-28 | Warnings | M007 |
| Topwin Speedy Enema | GLYCERIN | Health Chemical Pharmaceutical Co., Ltd | 3ba8c3d2-1780-42e1-bec5-8f98771d475e | 2026-07-27 | Warnings | M007 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1245686 | docusate sodium 50 MG in 5 mL Oral Solution | PSN | e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | 9 |
| 1245686 | docusate sodium 10 MG/ML Oral Solution | SCD | e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | 9 |
| 1245686 | docusate sodium 10 MG per 1 ML Oral Solution | SY | e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | 9 |
| 1245686 | docusate sodium 100 MG per 10 ML Oral Solution | SY | e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | 9 |
| 1245686 | docusate sodium 150 MG per 15 ML Oral Solution | SY | e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | 9 |
| 1245686 | DOSS Sodium 10 MG/ML Oral Solution | SY | e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | 9 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0121-0935-05 | 00121093505 | 5 mL in 1 CUP, UNIT-DOSE | 5 ml | Historical | ||||
| 0121-0935-16 | 00121093516 | 473 mL in 1 BOTTLE (0121-0935-16) | 473 ml | 2021-08-16 | 0000-00-00 | No | No | Current |
| 0121-0935-40 | 00121093540 | 4 TRAY in 1 CASE (0121-0935-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-0935-05) | 4 tray | 2021-08-16 | 0000-00-00 | No | No | Current |